150 related articles for article (PubMed ID: 31015005)
1. Mechanism of collapse of amorphous-based lyophilized cake induced by slow ramp during the shelf ramp process.
Ohori R; Akita T; Yamashita C
Int J Pharm; 2019 Jun; 564():461-471. PubMed ID: 31015005
[TBL] [Abstract][Full Text] [Related]
2. Effect of temperature ramp rate during the primary drying process on the properties of amorphous-based lyophilized cake, Part 2: Successful lyophilization by adopting a fast ramp rate during primary drying in protein formulations.
Ohori R; Akita T; Yamashita C
Eur J Pharm Biopharm; 2018 Sep; 130():83-95. PubMed ID: 29913271
[TBL] [Abstract][Full Text] [Related]
3. Determination of ice interface temperature, sublimation rate and the dried product resistance, and its application in the assessment of microcollapse using through-vial impedance spectroscopy.
Jeeraruangrattana Y; Smith G; Polygalov E; Ermolina I
Eur J Pharm Biopharm; 2020 Jul; 152():144-163. PubMed ID: 32353532
[TBL] [Abstract][Full Text] [Related]
4. Application of Optical Coherence Tomography Freeze-Drying Microscopy for Designing Lyophilization Process and Its Impact on Process Efficiency and Product Quality.
Korang-Yeboah M; Srinivasan C; Siddiqui A; Awotwe-Otoo D; Cruz CN; Muhammad A
AAPS PharmSciTech; 2018 Jan; 19(1):448-459. PubMed ID: 28785859
[TBL] [Abstract][Full Text] [Related]
5. Optimizing lyophilization primary drying: A vaccine case study with experimental and modeling techniques.
Najarian J; Metsi-Guckel E; Renawala HK; Grosse D; Sims A; Walter A; Sarkar A; Karande A
Int J Pharm; 2024 Jun; 659():124168. PubMed ID: 38663644
[TBL] [Abstract][Full Text] [Related]
6. Freezing process influences cake appearance of a lyophilized amorphous protein formulation with low solid content and high fill configuration.
Lu X; Kulkarni SS; Dong H; Tang Y; Yi L; Gupta S
Int J Pharm; 2023 Apr; 636():122803. PubMed ID: 36894041
[TBL] [Abstract][Full Text] [Related]
7. An integrated process analytical technology (PAT) approach to monitoring the effect of supercooling on lyophilization product and process parameters of model monoclonal antibody formulations.
Awotwe Otoo D; Agarabi C; Khan MA
J Pharm Sci; 2014 Jul; 103(7):2042-2052. PubMed ID: 24840395
[TBL] [Abstract][Full Text] [Related]
8. The graphical design space for the primary drying phase of freeze Drying: Factors affecting the dried product layer resistance.
Srinivasan JM; Sacha GA; Nail SL
Int J Pharm; 2023 Jan; 630():122417. PubMed ID: 36410667
[TBL] [Abstract][Full Text] [Related]
9. Modeling of heat and mass transfer processes for the gap-lyophilization system using the mannitol-trehalose-NaCl formulation.
Kuu WY; Doty MJ; Nisipeanu E; Rebbeck CL; Cho YK; Smit MH
J Pharm Sci; 2014 Sep; 103(9):2784-2796. PubMed ID: 24648334
[TBL] [Abstract][Full Text] [Related]
10. Determination of mass and heat transfer parameters during freeze-drying cycles of pharmaceutical products.
Hottot A; Vessot S; Andrieu J
PDA J Pharm Sci Technol; 2005; 59(2):138-53. PubMed ID: 15971546
[TBL] [Abstract][Full Text] [Related]
11. Cake shrinkage during freeze drying: a combined experimental and theoretical study.
Rambhatla S; Obert JP; Luthra S; Bhugra C; Pikal MJ
Pharm Dev Technol; 2005; 10(1):33-40. PubMed ID: 15776811
[TBL] [Abstract][Full Text] [Related]
12. Determination for dry layer resistance of sucrose under various primary drying conditions using a novel simulation program for designing pharmaceutical lyophilization cycle.
Kodama T; Sawada H; Hosomi H; Takeuchi M; Wakiyama N; Yonemochi E; Terada K
Int J Pharm; 2013 Aug; 452(1-2):180-7. PubMed ID: 23684561
[TBL] [Abstract][Full Text] [Related]
13. Optimizing the lyophilization cycle and the consequences of collapse on the pharmaceutical acceptability of Erwinia L-asparaginase.
Adams GD; Ramsay JR
J Pharm Sci; 1996 Dec; 85(12):1301-5. PubMed ID: 8961143
[TBL] [Abstract][Full Text] [Related]
14. The nonsteady state modeling of freeze drying: in-process product temperature and moisture content mapping and pharmaceutical product quality applications.
Pikal MJ; Cardon S; Bhugra C; Jameel F; Rambhatla S; Mascarenhas WJ; Akay HU
Pharm Dev Technol; 2005; 10(1):17-32. PubMed ID: 15776810
[TBL] [Abstract][Full Text] [Related]
15. Lyophilization of protein formulations in vials: investigation of the relationship between resistance to vapor flow during primary drying and small-scale product collapse.
Overcashier DE; Patapoff TW; Hsu CC
J Pharm Sci; 1999 Jul; 88(7):688-95. PubMed ID: 10393566
[TBL] [Abstract][Full Text] [Related]
16. Freeze drying of nanosuspensions, 2: the role of the critical formulation temperature on stability of drug nanosuspensions and its practical implication on process design.
Beirowski J; Inghelbrecht S; Arien A; Gieseler H
J Pharm Sci; 2011 Oct; 100(10):4471-81. PubMed ID: 21607957
[TBL] [Abstract][Full Text] [Related]
17. Formulation Screening and Freeze-Drying Process Optimization of Ginkgolide B Lyophilized Powder for Injection.
Liu D; Galvanin F; Yu Y
AAPS PharmSciTech; 2018 Feb; 19(2):541-550. PubMed ID: 28849380
[TBL] [Abstract][Full Text] [Related]
18. Freeze-drying of mannitol-trehalose-sodium chloride-based formulations: the impact of annealing on dry layer resistance to mass transfer and cake structure.
Lu X; Pikal MJ
Pharm Dev Technol; 2004; 9(1):85-95. PubMed ID: 15000469
[TBL] [Abstract][Full Text] [Related]
19. Rapid determination of dry layer mass transfer resistance for various pharmaceutical formulations during primary drying using product temperature profiles.
Kuu WY; Hardwick LM; Akers MJ
Int J Pharm; 2006 Apr; 313(1-2):99-113. PubMed ID: 16513303
[TBL] [Abstract][Full Text] [Related]
20. Annealing to optimize the primary drying rate, reduce freezing-induced drying rate heterogeneity, and determine T(g)' in pharmaceutical lyophilization.
Searles JA; Carpenter JF; Randolph TW
J Pharm Sci; 2001 Jul; 90(7):872-87. PubMed ID: 11458336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
